Cancer Immunomodulator Market Insights,Analysis,Segmentation-Worldwide Industry Players Are- ANI Pharmaceuticals,Baxter International and Amgen Forecast 2025
Immunomodulators work by blocking the growth signal for cancer cells and by stimulating the body's immune system to attack the cancer cells. The most common immunomodulators used for myeloma are thalidomide, lenalidomide and pomalidomide
View full press release